KRT88P and cancer: Therefore, screening for HBsAg & anti-HBc is strongly recommended for patients receiving with rituximab-containing chemotherapy, and antiviral prophylaxis should be considered in both HBsAg-positive cancer patients and those with resolved hepatitis B undergoing rituximab-containing chemotherapy.